Abstract: The invention comprises a method and apparatus for sampling a common tissue volume and/or a common skin layer skin of a person as a part of noninvasively determining an analyte property with an analyzer including: a set of detectors at least partially embedded in a probe housing, the probe housing comprising a sample side surface, the detectors including a first and second range of detection zones of differing radial distances from a first illumination zone and second illumination zone, respectively coupled to separate sources, with surface paths between the sources and detectors overlapping a common skin area during use.

Abstract: The invention comprises a method and apparatus for sampling optical pathways having a common tissue depth, such as a maximum mean depth of penetration in the dermis, with a common sample position of a person for analysis in a noninvasive analyte property determination system, comprising the steps of: probing skin with a range of illumination zone-to-detection zone distances with at least two wavelength ranges and detecting, using a set of detectors, illumination zone-to-detection zone distances having mean optical pathways probing the common tissue layer, such as without the mean optical pathways entering the subcutaneous fat layer of the person. Optionally, the skin tissue layers are modulated and/or treated via tissue displacement before and/or during data collection. Optionally, given illumination zone-to-detection zone distances are dynamically selected based upon a measure of state of the skin of the person.

Abstract: The invention comprises an apparatus, comprising: (1) a dissolvable tablet, comprising: a support matrix, the support matrix comprising at least two percent by mass a gassing agent, the gassing agent comprising at least one of: a carbonic acid, H2CO3; a bicarbonate, HCO3; a bicarbonate salt; a carbonate, CO32?; and a carbonate salt; and (2) at least one milligram of tetrahydrocannabinol, where the dissolvable tablet optionally includes an acid and a buffer at least partially separating the gassing agent and the acid, where the tetrahydrocannabinol is blended into the support matrix of the dissolvable tablet prior to formation of the dissolvable tablet and/or is infused into a pre-made tablet comprising the support matrix.

Abstract: The invention comprises a method and apparatus for sampling skin of a person as a part of noninvasive analyte property determination system, comprising the steps of: providing an analyzer, comprising: sources and at least three detectors at least partially embedded in a probe housing, the probe housing comprising a sample side surface, the detectors including: a range of differing radial distances from a first illumination zone; repetitively illuminating an illumination zone of the skin with photons in a range of 1200 to 2500 nm; detecting portions of the first photons with the at least three detectors; and using signals from the at least three detectors and a metric, respectively classifying the skin into a first, second, and third tissue state, the radial distances of the at least three detectors differing from each other by greater than ten percent.

Abstract: The invention comprises an applied force-optic analyzer used to determine a sample constituent concentration, a physical measure of the sample, and/or a state of the sample. The analyzer comprises: an electro-mechanical transducer affixed to skin of a subject; a controller, the controller providing a voltage waveform to the electro-mechanical transducer driving displacement of the skin and inducing a pressure wave into the skin; and a spectrometer interfaced to a sample site of the skin, the spectrometer comprising a set of sources and a set of detectors, where the controller is configured to collect signal from the set of detectors as a function of timing of the voltage waveform and apply a calibration model to the signal to determine the analyte concentration.

Abstract: The invention comprises a method and apparatus for sampling a common tissue volume and/or a common skin layer skin of a person as a part of noninvasive analyte property determination system, comprising the steps of: providing an analyzer, comprising at least three detectors at least partially embedded in a probe housing, the probe housing comprising a sample side surface, the detectors including a first and second range of detection zones of differing radial distances from a first illumination zone and second illumination zone, respectively coupled to separate sources; repetitively illuminating the illumination zones of the skin with photons in a range of 1200 to 2500 nm; and detecting portions of light from the sources with the at least three detectors, the detectors positioned on a common line with the sources.

Abstract: The invention comprises a method and apparatus for noninvasively determining state of a person, comprising the steps of: providing an analyzer comprising a first and second spectrometer unit and a main controller subsystem; replaceably attaching the first spectrometer unit to the person at a first illumination zone; the first spectrometer unit delivering first photons, from first illumination optics, along a first mean z-axis optical path normal to a first x/y-plane tangentially contacting the first illumination zone of the person; replaceably attaching a second spectrometer unit to the person at a second illumination zone; the second spectrometer delivering second photons, from second illumination optics, along a second mean z-axis optical path perpendicular to a second x/y-plane tangentially contacting the second illumination zone of the skin, the first x/y-plane noncoplanar with the second x/y-plane; and the main controller processing detected signals to generate at least one measure of state of the person

Abstract: The invention comprises a method for noninvasively determining a sample property, comprising controlling photon generation from a source and analyzing signal from a set of detectors; irradiating an illumination zone of skin with the photons; and detecting diffusely reflected photons from the skin, the set of detectors respectively optically coupled to a set of detection zones of the skin positioned along a spiral path between a first and second radial distance from the illumination zone, where a first detection zone of a first detector of the set of detectors extends radially outward from the illumination zone to at least an inward radial distance, from the illumination zone, of a second detection zone of a second detector of the set of detectors, where at least one detection zone of the set of detection zones has a central radial distance from the illumination zone between the first and second radial distances.

Abstract: The invention comprises a method and apparatus for selecting optical pathways sampling a common tissue layer, such as the dermis, of a person for analysis in a noninvasive analyte property determination systemy, comprising the steps of: probing skin with a range of illumination zone-to-detection zone distances with at least two wavelength ranges, which optionally overlap, and selecting, using a metric, illumination zone-to-detection zone distances having mean optical pathways probing the common tissue layer, such as without the mean optical pathways entering the subcutaneous fat layer of the person. Optionally, the skin tissue layers are modulated and/or treated via tissue displacement before and/or during data collection.

Abstract: The invention comprises a method and apparatus for sampling optical pathways having a common tissue depth, such as a maximum mean depth of penetration in the dermis, with a common detector of a person for analysis in a noninvasive analyte property determination system, comprising the steps of: probing skin with a range of illumination zone-to-detection zone distances with at least two wavelength ranges, which optionally overlap, and detecting, using a common detector, illumination zone-to-detection zone distances having mean optical pathways probing the common tissue layer, such as without the mean optical pathways entering the subcutaneous fat layer of the person. Optionally, the skin tissue layers are modulated and/or treated via tissue displacement before and/or during data collection.

Abstract: The invention comprises a method and apparatus for forming a beverage, comprising the steps of: dissolving a tablet in the beverage, the tablet containing tetrahydrocannabinol; forming gas bubbles, such as carbon dioxide, within the beverage through a chemical reaction; and mixing the tetrahydrocannabinol in the beverage through motion of the gas bubbles, such as where the tetrahydrocannabinol is maintained, after the step of mixing, in suspension in the beverage for a period of at least five minutes through at least movement of the gas bubbles.

Abstract: The invention comprises a method and apparatus for forming a Cannabis product, comprising the steps of: providing a tetrahydrocannabinol concentrate, the tetrahydrocannabinol concentrate comprising: a purity of at least forty percent and a tetrahydrocannabinol (THC) viscosity in excess of 4,000 centipoise at 25° C.; combining with the tetrahydrocannabinol concentrate a second substance, the second substance comprising a second substance viscosity less than the THC viscosity to form a THC compound; heating the THC compound to greater than 40° C. to yield a THC compound viscosity of less than 1,000 centipoise; and adding the THC compound to a product substance to form a THC containing product, the THC containing product comprising a THC containing product viscosity greater than 5,000 centipoise at 25° C.

Abstract: The invention comprises a method, comprising the steps of: pressing into a dissolvable tablet at least one of: a carbonic acid, H2CO3; a bicarbonate, HCO3?; a salt of bicarbonate; a carbonate, CO32?; and a salt of carbonate; and distributing at least one milligram of a Cannabis product in the dissolvable tablet, where the Cannabis product is optionally and preferably at least one milligram of tetrahydrocannabinol. Optionally and preferably at least one of: a hydrogen phosphate; an ionic phosphate; monocalcium phosphate; a phosphate; and an acid is incorporated into the dissolvable tablet.

Abstract: The invention comprises a method and apparatus for forming a Cannabis product, comprising the steps of: in a first process, decreasing viscosity of a tetrahydrocannabinol stock, of at least fifty percent purity, by at least two thousand centipoise through: (1) the addition of at least one of: ethanol, butter, a fat, and an oil to form an intermediate tetrahydrocannabinol compound and (2) heating the intermediate tetrahydrocannabinol compound to at least 40° C.; in a subsequent process, further reducing viscosity of the intermediate tetrahydrocannabinol compound to less than 100 centipoise by diluting the tetrahydrocannabinol compound with water at a ratio of at least ten parts water to one part tetrahydrocannabinol stock, by at least one of mass and volume, to form a liquid THC product; and packaging the liquid THC product in a container for distribution from a manufacturing point to a point of sale.

Abstract: The invention comprises a method and apparatus for holding a Cannabis product, such as a beverage container having a resealable closure that remains affixed to the beverage container when in both an open position and a closed position, where a cavity within the container comprises at least two servings of tetrahydrocannabinol (THC). The resealable closure optionally includes a slideable/rotatable element that is slideable/rotatable along a horizontal plane relative to an upper surface of the beverage container, the slideable/rotatable closure element alternatingly closing an opening in the lid when in a first position and allowing access through the opening when in a second position. The resealable container in combination with graphical THC serving size indicators allows a consumer to consume a known amount of THC.

Abstract: The invention comprises a method and apparatus for holding a Cannabis product, such as a THC containing beverage, comprising the steps of: preparing a concentrated emulsion of tetrahydrocannabinol with a concentration exceeding two thousand milligrams per twelve ounces; diluting the concentrated emulsion in a bright tank to yield a diluted emulsion comprising: (1) a tetrahydrocannabinol concentration of less than two hundred milligrams per twelve ounces and (2) a solution with a viscosity of less than twenty millipascal-seconds; and then pumping the diluted emulsion from the bright tank to a cavity of a beverage container, such as where the diluted emulsion comprises a mean micelle diameter greater than 600 nm.

Abstract: The invention comprises a method and/or an apparatus for operating a Cannabis facility generating a tetrahydrocannabinol (THC) containing product, comprising the step of labeling the THC containing product with a matrix bar code/quick response (QR) code, the cannabis containing product comprising at least two milligrams of a tetrahydrocannabinol substance, the QR code linking to product information associated with the THC containing product, the product information comprising at least one of a location, date of harvest, strain, and/or type of a plant containing a tetrahydrocannabinol substance in the THC containing product; an extraction method; a date and/or a location of manufacture of the THC product; a related laboratory report; and/or a link to a related web page.

Abstract: The invention comprises a method and apparatus for forming a Cannabis product, comprising the steps of: preparing a tetrahydrocannabinol emulsion comprising particles, the particles comprising: (1) a first peak concentration of the particles, as a function of particle size, less than nine hundred nanometers in diameter; and (2) a second peak concentration of the particles greater than nine hundred nanometers in diameter and adding the tetrahydrocannabinol emulsion to at least one of: an edible, a beverage, an additive for use in a vape cartridge, and a pre-roll, where a mixer is used to form the particles containing tetrahydrocannabinol and where the particles comprise at least one of: a micelle comprising the tetrahydrocannabinol; a droplet of the tetrahydrocannabinol; a lipid bilayer cell comprising the tetrahydrocannabinol; a mixed droplet of both the tetrahydrocannabinol and an oil; and the tetrahydrocannabinol and at least one-tenth of a percent ethanol.

Abstract: The invention comprises a method and apparatus for forming a Cannabis product, comprising the steps of: combining tetrahydrocannabinol and ethanol to form a THC-alcohol compound, the THC-alcohol compound comprising less than fifty percent water by mass and subjecting the THC-alcohol compound to a shear force in excess of 100 or 50,000 sec?1. Optionally and preferably, formation of the Cannabis product results after successive steps of reducing viscosity of the tetrahydrocannabinol compound, such as by 2000+ cP and 20+ cP, or after reversing a first viscosity reducing step of 2000+ cP with a subsequent viscosity increase of 2000+ cP, such as in the formation of a THC containing drink, edible, vape pen solution, or preroll.

Abstract: The invention comprises a method and apparatus for holding a Cannabis product, such as a soda or a beverage, comprising: a container comprising a cavity at least partially enclosed within a base and at least one side extending upwards from the base; an emulsion in the cavity, the emulsion comprising at least: water and tetrahydrocannabinol; and a label on the at least one side, the label comprising a set of at least three graphical serving size indicators correspondingly positioned at at least three differing vertical locations from the base, where a mean particle size of the beverage is preferably less than one thousand nanometers in diameter.